John M. Evans, CEO of Beam Therapeutics BEAM, has filed 0 purchases and 19 sales on the open market. Over the past 12 months that comes to a net sale of $4.5M. The latest trade was on 04/01.

JE

JE

John M. Evans

CEO

Company

Beam Therapeutics BEAM

First filing

23/03/31

Trades

48 trades

Buys / sales

0 / 19

12-month net buying

−$4.5M

Last trade

04/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	04/01	04/06	30,078 sh	$24.58	$739,317.24	−2.8%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	03/30–03/31	04/01	50,000 sh2 trades	$22.57avg.	$1,128,250	−4.8%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	01/29–01/30	02/02	50,000 sh4 trades	$28.87avg.	$1,443,388.23	−4.8%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	25/10/01–25/10/02	25/10/03	50,000 sh2 trades	$24.57avg.	$1,228,500	−4.8%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	25/04/01	25/04/03	30,663 sh	$18.35	$562,666.05	−3.0%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	25/01/30	25/02/03	30,000 sh2 trades	$26.75avg.	$802,606	−3.2%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/09/30	24/10/02	60,000 sh	$24.60	$1,476,000	−6.0%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/06/27	24/06/28	60,000 sh	$24.50	$1,470,000	−5.7%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/04/01	24/04/03	18,102 sh	$32.13	$581,617.26	−1.7%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/03/28	24/04/01	60,000 sh	$33.86	$2,031,600	−5.7%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	24/01/31	24/02/02	60,000 sh	$25.33	$1,519,800	−5.4%
Beam TherapeuticsBEAM	Open-market sale10b5-1 plan	23/04/03–23/04/04	23/04/05	11,654 sh2 trades	$29.63avg.	$345,311.28	−1.0%